Evidence map›Paper›PMID 41743374›Full record

ReviewTherapeutic advances in gastroenterology2026

Diarrhea management: from pathophysiology to microbiota modulation.

Giovanni Marasco, David Meacci, Giovanni Sarnelli, Cesare Tosetti, Cesare Cremon, Edoardo Vincenzo Savarino, Giovanni Barbara

Abstract readReview
In one paragraph

Review in Therapeutic advances in gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Giovanni MarascoIRCCS Azienda Ospedaliero Universitaria di Bologna, Bologna, Italy.
David MeacciIRCCS Azienda Ospedaliero Universitaria di Bologna, Bologna, Italy.
Giovanni SarnelliDigestive and Nutritional Pathophysiology Unit, Department of Clinical Medicine and Surgery, University of Naples "Federico II," Naples, Italy.
Cesare TosettiPrimary Care, Porretta Terme, Bologna, Italy.
Cesare CremonIRCCS Azienda Ospedaliero Universitaria di Bologna, Bologna, Italy.ORCID https://orcid.org/0000-0002-7777-2936
Edoardo Vincenzo SavarinoGastroenterology Unit, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.
Giovanni BarbaraIRCCS Azienda Ospedaliero Universitaria di Bologna, Via Massarenti, 9, Bologna 40138, Italy.ORCID https://orcid.org/0000-0001-9745-0726

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diarrhea, whether acute or chronic, is a common clinical condition with numerous causes that collectively impose significant health, economic, social, and psychological burdens worldwide. Based on its duration, diarrhea is classified as acute when lasting less than 2 weeks and chronic when persisting for more than 4 weeks. From a pathophysiological standpoint, diarrhea can be categorized into four main types: osmotic, secretory, inflammatory, and motility-related. Acute diarrhea is most commonly caused by infectious gastroenteritis and tends to have a self-limited course. In contrast, chronic diarrhea presents a more complex diagnostic challenge due to its varied etiologies and clinical presentations. A shared feature among many causes of both acute and chronic diarrhea is an alteration in the gut microbiota, a condition referred to as dysbiosis. While acute infections often result in temporary microbial imbalance, chronic conditions such as irritable bowel syndrome and symptomatic uncomplicated diverticular disease are associated with persistent dysbiosis. This review aims to explore the most prevalent causes and underlying mechanisms of acute and chronic diarrhea, with a particular focus on the role of the gut microbiota. It will also examine the principal therapeutic strategies aimed at modulating intestinal microbiota, including prebiotics, probiotics, antibiotics, and fecal microbiota transplantation.

Indexed as

acute diarrheaantibioticschronic diarrheadiverticular diseasedysbiosisfecal microbiota transplantationgut microbiotainflammatory bowel diseaseirritable bowel syndromeprebioticsprobioticssmall intestine bacterial overgrowth

Identifiers

PMID41743374
PMCPMC12929882

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.